Last edition
News about Ingredients
Regeneron's Covid treatment review extended by FDA
The U.S. FDA is broadening the survey date for Regeneron Pharmaceuticals' COVID-19 immune response mixed drink back by 90 days. The choice was made after information showed it might assist with forestalling disease.
Ingredients | 16/04/2022 | By Sudeep Soparkar | 540
Neem extract has antiviral properties against coronavirus, finds IISER researchers
Researchers from Indian Institute of Science Education and Research (IISER) Kolkata during their research have found that Neem extract derived from the bark of Neem tree has the antiviral properties against coronavirus and can be used to treat and reduce the spread of SARS-Cov-2 that is causing the deadly Covid-19 disease among the people
Ingredients | 06/03/2022 | By Darshana | 1002
The full integration of drug substance R&D and manufacturing follows a year after the company's acquisition of its Alnwick, UK site and provides a more streamlined approach from candidate selection through to commercialization. Quotient Sciences Translational Pharmaceutics approach combining manufacturing and clinical dosing at a single organization
Ingredients | 18/02/2022 | By Darshana | 854
Government approves PLI scheme to boost domestic API production: Dr Mansukh Mandaviya
With a view to attain self-reliance and reduce import dependence in critical APIs, the Centre has approved ?Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) In India
Ingredients | 23/12/2021 | By Darshana | 856
Panacea Biotec supplies maiden shipment of Sputnik V's second component produced in India
The Russian Direct Investment Fund (RDIF) and Panacea Biotec have announced the supply of the first shipment out of one million doses of the second component (human adenovirus serotype 5) of the Russian Sputnik V coronavirus vaccine manufactured by Panacea Biotec for sale in India, the company said in a statement
Ingredients | 08/09/2021 | By Darshana | 764
AffaMed Therapeutics, a global clinical stage biopharmaceutical company, announced during the recent "China International Trade in Services Fair 2021" a strategic cooperation partnership with Beijing Tiantan Hospital of Capital Medical University and Beijing Infinite Brain Technologies (IBT)
Ingredients | 07/09/2021 | By Darshana | 486
Pharma technology vocational course introduced by Telangana not approved by PCI
The new pharma technology vocational course introduced by the Board of Intermediate (BIE) of Telangana state is expected to face tough hurdles for the students as the BIE has not taken any kind of approval from the Pharmacy Council of India (PCI)
Ingredients | 01/09/2021 | By Darshana | 1001
Roche announced that the cobas MTB and cobas MTB-RIF/INH tests for use on the cobas 6800/8800 Systems are included as part of the updated World Health Organization (WHO) policy guidelines on nucleic acid amplification tests (NAATs) to detect tuberculosis (TB) and drug-resistant TB
Ingredients | 10/07/2021 | By Darshana | 427
DoP re-invites applications to manufacture erythromycin thiocyanate under PLI scheme
The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under the production linked incentive (PLI) scheme for promotion of domestic manufacturing of 41 KSMs/DIs/APIs
Ingredients | 07/07/2021 | By Darshana | 439
Centrient Pharmaceuticals boosting statins API manufacturing capacity
Centrient Pharmaceuticals today announced to have started production at its new statins manufacturing unit. With the building of its second dedicated unit on the Toansa site in India now completed. The company will double its statins production capacity that will enable it to meet the growing demand for its sustainably manufactured Atorvastatin
Ingredients | 24/06/2021 | By Darshana | 502
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy